Skip to main content

Year: 2025

House of Doge – The Official Corporate Arm of the Dogecoin Foundation, and Merger Partner Brag House Holdings Confirm Triestina Sponsorship with Dogecoin as Primary Kit and Stadium Mark

NEW YORK and MIAMI, Oct. 30, 2025 (GLOBE NEWSWIRE) — House of Doge Inc., the official corporate arm of the Dogecoin Foundation, together with merger partner Brag House Holdings, Inc. (NASDAQ: TBH), and U.S. Triestina Calcio 1918, today announced a multi-asset sponsorship that places Dogecoin front-and-center on the club’s official match jerseys, with House of Doge featured on select secondary placements. The announcement follows House of Doge’s recent equity acquisition of Triestina, which made history as the first cryptocurrency company to become a major owner in a professional football club. The activation begins this season and continues through the 2026/27 campaign. WHAT FANS WILL SEEFront-of-jersey cresting: Dogecoin featured as the main chest branding on Triestina’s official match kits Secondary kit placements: House of...

Continue reading

Moleculin to Highlight its Ongoing Phase 3 Acute Myeloid Leukemia “MIRACLE” Clinical Trial at the 14th Annual Acute Leukemia Meeting

HOUSTON, Oct. 30, 2025 (GLOBE NEWSWIRE) — Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat cancers and viral infections, today announced it will present at the 14th Annual Acute Leukemia Meeting being held October 30-31, 2025 at the MD Anderson Cancer Center Spain Foundation in Madrid, Spain. Details of the presentation are as follows: Title: L-Annamycin – Non-Cardiotoxic Anthracycline; MIRACLE Pivotal AML StudySession: Lunch Session: MoleculinPresenter: Dr. Paul Waymack, Senior Chief Medical Officer of MoleculinDate and Time: Thursday, October 30th at 2:35 PM CEST As part of the presentation, Dr. Waymack will discuss the Company’s ongoing pivotal Phase 2B/3, multi-center, randomized, double-blind,...

Continue reading

NanoXplore Closes Bought Deal Life Private Placement of $25,728,840

Not for distribution to United States newswire services or for dissemination in the United States MONTREAL, Oct. 30, 2025 (GLOBE NEWSWIRE) — NanoXplore Inc. (“NanoXplore” or the “Corporation”) (TSX: GRA and OTCQX: NNXPF), a world-leading graphene company, is pleased to announce that it has closed its previously announced bought deal private placement whereby it issued 10,720,350 common shares in the capital of the Corporation (“Common Shares”) at a price of $2.40 per Common Share (the “Offering Price”) for gross proceeds of $25,728,840 (the “Offering“). The Offering was conducted by a syndicate of underwriters co-led by Ventum Financial Corp. and Cormark Securities Inc., and which included National Bank Financial Inc., RBC Dominion Securities Inc., Paradigm Capital Inc. and Raymond James Ltd. (together, the “Underwriters“). The...

Continue reading

Akari Therapeutics Announces Formation of Scientific Advisory Board and Inaugural Appointment of Renowned Medical Oncologist, Sara A. Hurvitz, MD, FACP

Dr. Hurvitz is an international expert in oncology and a recognized clinical research leader with extensive experience leading clinical trials spanning all phases BOSTON and LONDON, Oct. 30, 2025 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payload antibody drug conjugates (ADCs), today announced the formation of its Scientific Advisory Board (SAB) and inaugural appointment of Dr. Sara Hurvitz. “The formation of our SAB marks an important step in advancing Akari’s scientific and clinical strategy, and we are honored to welcome Dr. Sara Hurvitz as its inaugural member,” commented Abizer Gaslightwala, President and Chief Executive Officer of Akari Therapeutics. “In addition to her wealth of knowledge around ADCs, Dr. Hurvitz brings exceptional clinical expertise in...

Continue reading

Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence

New collaboration provides services to streamline patient support, reduce administrative burden, and expand access to advanced TMS treatment across Elite DNA Clinics MALVERN, Pa., Oct. 30, 2025 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced an exclusive three-year agreement with Elite DNA Behavioral Health, one of Florida’s largest and fastest-growing mental health networks, to become the sole provider of transcranial magnetic stimulation (TMS) devices across Elite DNA’s 30+ locations. The collaboration also leverages the Company’s Greenbrook platform to provide Elite DNA with expanded fee-based, operational and patient-support services. “We...

Continue reading

Worksport Announces Official Launch Date for SOLIS and COR Clean Energy Products

Innovative solar tonneau and portable power system officially available for order November 28, 2025, marking Worksport’s entry into a new era of clean energy solutions West Seneca, New York, Oct. 30, 2025 (GLOBE NEWSWIRE) — Worksport Ltd. (NASDAQ: WKSP) (“Worksport” or the “Company”), a U.S.-based innovator in advanced manufacturing and distributed clean energy technologies, serving both consumer and industrial markets, today announced the official launch date for its flagship SOLIS™ Solar Tonneau Cover and COR™ Portable Energy Storage System — both available for order starting November 28, 2025. A select group of early-access customers will be invited to place pre-launch orders ahead of the official date as Worksport initiates the countdown to its most anticipated product debut yet. Product Launch and Pricing Details The...

Continue reading

Banzai to Host Third Quarter 2025 Financial Results Conference Call on Friday, November 14, 2025 at 4:30 p.m. Eastern Time

SEATTLE, Oct. 30, 2025 (GLOBE NEWSWIRE) — Banzai International, Inc. (NASDAQ: BNZI) (“Banzai” or the “Company”), a leading marketing technology company that provides essential marketing and sales solutions, will hold a conference call on Friday, November 14, 2025, at 4:30 p.m. Eastern Time to discuss its financial results for the third quarter ended September 30, 2025, as well as review ongoing initiatives and anticipated milestones. Banzai Founder & CEO Joe Davy and CFO Dean Ditto will host the conference call, followed by a question-and-answer session. The conference call will be accompanied by a presentation, which can be viewed during the webcast or accessed via the investor relations section of the Company’s website here. To access the call, please use the following information:Date: Friday, November 14, 2025Time: 4:30...

Continue reading

First Mid Bancshares, Inc. Announces Acquisition of Two Rivers Financial Group, Inc.

MATTOON, Ill. and BURLINGTON, Iowa, Oct. 30, 2025 (GLOBE NEWSWIRE) — First Mid Bancshares, Inc. (NASDAQ: FMBH) (“First Mid”) and Two Rivers Financial Group, Inc. (OTCQX: TRVR) (“Two Rivers”) announced the execution of a definitive agreement dated October 29, 2025 under which Two Rivers will merge with First Mid in a 100% stock transaction, expanding First Mid’s presence into attractive Iowa markets. Two Rivers is the parent company of Two Rivers Bank & Trust and is headquartered in Burlington, Iowa, operating 14 branches in central and southeastern Iowa. As of September 30, 2025, Two Rivers had approximately $1.1 billion in total assets, $901 million in loans, $988 million in deposits and $1.2 billion in trust and wealth management assets under management. Two Rivers traces its origins to 1904, when it was established as Burlington...

Continue reading

SunPower Executes Major Sales Force Expansion Following Sunder Merger

OREM, Utah, Oct. 30, 2025 (GLOBE NEWSWIRE) — SunPower Inc. (Nasdaq: SPWR) a solar technology, services, and installation company, this morning announced the successful integration of the Sunder salesforce into the company — as SunPower continues to execute on plan and expects to achieve record revenue of $83.3 million and record operating income of $3.5 million in Q4 2025. Eric Nielsen, SunPower’s EVP of Sales said, “I am happy to report the integration of Sunder’s salesforce into SunPower has been seamless and as a result, has enabled our team to continue to execute on plan without missing a beat. In addition, this deal has been well received across the industry — evidenced by the fact that we have continued to receive inbound interest from salespeople eager to join our team. As of today, we have added 266 new salespeople.” Dan...

Continue reading

Kojamo plc’s Interim Report 1 January–30 September 2025

Kojamo plc Stock Exchange Release, 30 October 2025 at 2.00 p.m. EET Kojamo plc’s Interim Report 1 January–30 September 2025 Occupancy rate improved, total revenue and net rental income increased This is a summary of the January–September Interim Report, which is in its entirety attached to this release and can be downloaded from the company’s website at www.kojamo.fi/investors. Unless otherwise stated, the comparison figures in brackets refer to the corresponding period of the previous year. The figures in this Interim Report have not been audited. Summary of July–September 2025Total revenue increased by 0.4 per cent to EUR 113.6 (113.2) million. Net rental income increased by 0.3 per cent totalling EUR 86.0 (85.7) million. Net rental income represented 75.7 (75.8) per cent of revenue. Result before taxes was EUR 32.8 (50.6) million....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.